Method and Apparatus for Ablating a Target Volume

The USPTO published patent application US20260090837A1 for a method and apparatus supporting ablation of a target volume in medical procedures. The invention describes a control circuit that registers three-dimensional patient imaging with ablation zone information to generate two-dimensional coverage representations. Inventors include Hojjatollah Fallahi, Dane Olson, and Gael Luis Boivin.

Minimally Invasive Access Channels Into Bodily Regions

USPTO published patent application US20260090836A1 filed by MicroCube, LLC for access devices and methods to create channels for introducing working devices into anatomical regions. The invention uses visualization modalities (endoscopes, ultrasound) to create access channels that are then used for diagnostic, therapeutic, or preventive procedures, with endometrial ablation as a specific example application.

Shunting Catheters and Methods for Tisusal Removal

The USPTO published patent application US20260090834A1 for shunting catheters and tissue removal methods. The application (No. 18899694) was filed September 27, 2024 and names inventors Rani Abdullah Mahmoudi, Ajay Kumar Dass, and Wei Gan. The invention relates to catheter systems with tissue-removal assemblies for creating shunts in patients.

Tissue sealing instrument patent with dual sealing electrodes

The USPTO published patent application US20260090833A1 for a tissue sealing instrument with dual sealing electrodes. The invention features two jaws with sealing electrodes, where one jaw includes a cutting electrode held in a flexible plastic body within a narrow groove, while the opposing jaw contains an elastic counter support seated in a wider recess. Inventors include Volker Mayer, Rolf Weiler, and colleagues. Filing date was September 19, 2025.

Calibration Block for Surgical Fiducial Marker Arrays

USPTO published patent application US20260090832A1 for a calibration block designed for surgical fiducial marker arrays. The invention includes a main body with top and side faces, surgical fiducial markers in an asymmetrical arrangement, and screw openings for calibration purposes. Inventors include Jesse Harrison Gallant, Osamah Choudhry, Christopher Morley, and Florentin Jonas Liebmann. Filing date was September 29, 2024, under application number 18900842.

Expandable Veterinary Orthopedic Implant System

The USPTO published patent application US20260090831A1 by IN LIFE VET SA covering an expandable veterinary orthopedic implant system and manufacturing process. The application describes an implant with flanges that expands via support arm pivoting when distal and proximal ends are brought together, with an expansion sleeve mechanism enabling controlled deployment. Filed September 25, 2025.

Hip fracture fixation system, patent US20260090830A1, published 2nd Apr

Hip fracture fixation system, patent US20260090830A1, published 2nd Apr

Doxycycline Mouthwash for COVID-19 Prevention

USPTO published patent application US20260091045A1 for a preventative mouthwash containing doxycycline (100-400mg dosage) for COVID-19 infection prevention. Inventor Bruce Roseman's application describes a gargling method using 5-20mL of the mouthwash twice daily for 5-10 days. The application was filed October 2, 2024 and published April 2, 2026.

Carbasalate Calcium Application for Hydrocephalus Treatment

The USPTO published patent application US20260091044A1 by Tianjin University covering the use of carbasalate calcium as the sole or primary active ingredient for treating hydrocephalus. The application includes zebrafish model experimental data demonstrating significant reduction in fourth ventricle area and improvements in swimming metrics. No regulatory compliance deadlines or penalties apply to this patent application publication.

Compositions and Methods for Treating Mycobacterium Infections

USPTO published patent application US20260091043A1 for compositions and methods treating infections caused by Mycobacteriaceae family pathogens, including those causing tuberculosis. Inventors John David Wild, Jeremy Joseph Yang, and Sean Ekins filed the application on September 20, 2023. The application claims priority to Application No. 19113756 and covers novel therapeutic approaches to bacterial infections.